These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29785580)

  • 1. A comprehensive review and meta-analysis of risk factors for statin-induced myopathy.
    Nguyen KA; Li L; Lu D; Yazdanparast A; Wang L; Kreutz RP; Whipple EC; Schleyer TK
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1099-1109. PubMed ID: 29785580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis.
    Xiang Q; Chen SQ; Ma LY; Hu K; Zhang Z; Mu GY; Xie QF; Zhang XD; Cui YM
    Pharmacogenomics J; 2018 Dec; 18(6):721-729. PubMed ID: 30250148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of GATM polymorphism with statin-induced myopathy: a systematic review and meta-analysis.
    Liu M; Fan F; Zhang Y; Li J
    Eur J Clin Pharmacol; 2021 Mar; 77(3):349-357. PubMed ID: 33051696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin myotoxicity: a review of genetic susceptibility factors.
    Needham M; Mastaglia FL
    Neuromuscul Disord; 2014 Jan; 24(1):4-15. PubMed ID: 24176465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.
    Brunham LR; Baker S; Mammen A; Mancini GBJ; Rosenson RS
    Cardiovasc Res; 2018 Jul; 114(8):1073-1081. PubMed ID: 29878063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin-fibrate combination therapy.
    Shek A; Ferrill MJ
    Ann Pharmacother; 2001; 35(7-8):908-17. PubMed ID: 11485144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomewide Association Study of Statin-Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research Datalink.
    Carr DF; Francis B; Jorgensen AL; Zhang E; Chinoy H; Heckbert SR; Bis JC; Brody JA; Floyd JS; Psaty BM; Molokhia M; Lapeyre-Mestre M; Conforti A; Alfirevic A; van Staa T; Pirmohamed M
    Clin Pharmacol Ther; 2019 Dec; 106(6):1353-1361. PubMed ID: 31220337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between single-nucleotide polymorphisms and statin-induced myopathy: a mixed-effects model meta-analysis.
    Xiang Q; Zhang XD; Mu GY; Wang Z; Liu ZY; Xie QF; Hu K; Zhang Z; Ma LY; Jiang J; Cui YM
    Eur J Clin Pharmacol; 2021 Apr; 77(4):569-581. PubMed ID: 33150478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic predisposition to statin myopathy.
    Vladutiu GD
    Curr Opin Rheumatol; 2008 Nov; 20(6):648-55. PubMed ID: 18946323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
    Brunham LR; Lansberg PJ; Zhang L; Miao F; Carter C; Hovingh GK; Visscher H; Jukema JW; Stalenhoef AF; Ross CJ; Carleton BC; Kastelein JJ; Hayden MR
    Pharmacogenomics J; 2012 Jun; 12(3):233-7. PubMed ID: 21243006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.
    Mangravite LM; Engelhardt BE; Medina MW; Smith JD; Brown CD; Chasman DI; Mecham BH; Howie B; Shim H; Naidoo D; Feng Q; Rieder MJ; Chen YD; Rotter JI; Ridker PM; Hopewell JC; Parish S; Armitage J; Collins R; Wilke RA; Nickerson DA; Stephens M; Krauss RM
    Nature; 2013 Oct; 502(7471):377-80. PubMed ID: 23995691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myopathy in older people receiving statin therapy: a systematic review and meta-analysis.
    Iwere RB; Hewitt J
    Br J Clin Pharmacol; 2015 Sep; 80(3):363-71. PubMed ID: 26032930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetics of statin-induced myopathy.
    Ghatak A; Faheem O; Thompson PD
    Atherosclerosis; 2010 Jun; 210(2):337-43. PubMed ID: 20042189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics and statin-related myopathy: what do we know?
    Turner RM; Radman I; Bozina N; Alfirevic A
    Pharmacogenomics; 2020 Aug; 21(12):821-825. PubMed ID: 32723135
    [No Abstract]   [Full Text] [Related]  

  • 15. GATM polymorphism associated with the risk for statin-induced myopathy does not replicate in case-control analysis of 715 dyslipidemic individuals.
    Luzum JA; Kitzmiller JP; Isackson PJ; Ma C; Medina MW; Dauki AM; Mikulik EB; Ochs-Balcom HM; Vladutiu GD
    Cell Metab; 2015 Apr; 21(4):622-7. PubMed ID: 25863251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
    Nichols GA; Koro CE
    Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin induced myotoxicity.
    Sathasivam S
    Eur J Intern Med; 2012 Jun; 23(4):317-24. PubMed ID: 22560377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intolerance.
    Bigossi M; Maroteau C; Dawed AY; Taylor A; Srinivasan S; Melhem AL; Pearson ER; Pola R; Palmer CNA; Siddiqui MK
    Eur Heart J Cardiovasc Pharmacother; 2023 Sep; 9(6):536-545. PubMed ID: 37253618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin-related myotoxicity.
    Fernandes V; Santos MJ; Pérez A
    Endocrinol Nutr; 2016 May; 63(5):239-49. PubMed ID: 27005745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approach to clinical and genetic characterization of statin-induced myopathy.
    Feng Q
    Methods Mol Biol; 2014; 1175():67-90. PubMed ID: 25150867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.